The news clearly concerns CVS Health (NYSE:CVS), but CVS is not included in the provided active_symbols list, so no valid ticker can be returned.
CVS Health tops second-quarter estimates, raises full-year profit outlook Proactive Wed, August 5, 2026 at 4:53 PM GMT+2 1 min read CVS CVS Health tops second-quarter estimates, raises full-year profit outlook Proactive uses images sourced from Shutterstock CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue rose 7. 3% year-over-year to $106.
1 billion, above analyst estimates of $100. 11 billion. Adjusted earnings per share came in at $2.
58, up 43% from a year earlier and well ahead of the $1. 85 consensus estimate. Operating income nearly doubled to $4.
7 billion, compared with estimates of $3. 94 billion, while net income reached $3 billion versus expectations of $2. 36 billion.
The company raised its full-year adjusted EPS guidance to a range of $7. 90 to $8. 10, up from a prior estimate of $7.
45. CVS also lifted its forecast for cash flow from operations to at least $11. 5 billion, up from a previous outlook of at least $9.
5 billion. By segment, Health Care Benefits revenue rose 3. 5% to $37.
5 billion, Health Services revenue climbed 11. 5% to $51. 8 billion, and Pharmacy & Consumer Wellness revenue was flat at $33.
8 billion. On the earnings call, the company said it is "maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds. " Shares of CVS Health were down 5.
7% in Wednesday morning trading.
Oraklio AI Trading Intelligence
Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls - updated continuously throughout the trading day.
Get started freeAlready have an account? Sign in →